Felicaribacterium prausnitzi and desulfobibriopigel for use in the treatment or prevention of diabetes and bowel disease

摘要

The present invention relates generally to medicine. More specifically, the present invention relates to the use of synergistic probiotic bacteria as a health intervention. In particular, the invention relates to the treatment of a disease associated with a decrease in butyrate levels or a disease associated with a reduction in the number of Faecalibacterium prausnitzi bacteria or a small number of Fecalibacterium prausnitzi bacteria or Felicaribacterium prausnitzi strain for use in prevention, and (i) producing acetate, (ii) consuming lactate, (iii) having the ability to be an electron acceptor Bacterial strains having one or more are provided.